Famphur

DB11408

small molecule vet_approved

Deskripsi

Struktur Molekul 2D

Berat 325.33
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

368 Data
Leuprolide The risk or severity of QTc prolongation can be increased when Famphur is combined with Leuprolide.
Goserelin The risk or severity of QTc prolongation can be increased when Famphur is combined with Goserelin.
Erythromycin The risk or severity of QTc prolongation can be increased when Famphur is combined with Erythromycin.
Azithromycin The risk or severity of QTc prolongation can be increased when Famphur is combined with Azithromycin.
Moxifloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Moxifloxacin.
Ranolazine The risk or severity of QTc prolongation can be increased when Famphur is combined with Ranolazine.
Sulfisoxazole The risk or severity of QTc prolongation can be increased when Famphur is combined with Sulfisoxazole.
Amitriptyline The risk or severity of QTc prolongation can be increased when Famphur is combined with Amitriptyline.
Methadone The risk or severity of QTc prolongation can be increased when Famphur is combined with Methadone.
Diltiazem The risk or severity of QTc prolongation can be increased when Famphur is combined with Diltiazem.
Clozapine The risk or severity of QTc prolongation can be increased when Famphur is combined with Clozapine.
Sulpiride The risk or severity of QTc prolongation can be increased when Famphur is combined with Sulpiride.
Nimodipine The risk or severity of QTc prolongation can be increased when Famphur is combined with Nimodipine.
Promazine The risk or severity of QTc prolongation can be increased when Famphur is combined with Promazine.
Prochlorperazine The risk or severity of QTc prolongation can be increased when Famphur is combined with Prochlorperazine.
Droperidol The risk or severity of QTc prolongation can be increased when Famphur is combined with Droperidol.
Imipramine The risk or severity of QTc prolongation can be increased when Famphur is combined with Imipramine.
Chlorpromazine The risk or severity of QTc prolongation can be increased when Famphur is combined with Chlorpromazine.
Oxaliplatin The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Famphur.
Ciprofloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Ciprofloxacin.
Fluorouracil The risk or severity of QTc prolongation can be increased when Famphur is combined with Fluorouracil.
Perflutren The risk or severity of QTc prolongation can be increased when Famphur is combined with Perflutren.
Cinnarizine The risk or severity of QTc prolongation can be increased when Famphur is combined with Cinnarizine.
Atropine The risk or severity of QTc prolongation can be increased when Famphur is combined with Atropine.
Chloroquine The risk or severity of QTc prolongation can be increased when Famphur is combined with Chloroquine.
Efavirenz The risk or severity of QTc prolongation can be increased when Famphur is combined with Efavirenz.
Adenosine The risk or severity of QTc prolongation can be increased when Famphur is combined with Adenosine.
Pentamidine The risk or severity of QTc prolongation can be increased when Famphur is combined with Pentamidine.
Gadobenic acid The risk or severity of QTc prolongation can be increased when Famphur is combined with Gadobenic acid.
Carbinoxamine The risk or severity of QTc prolongation can be increased when Famphur is combined with Carbinoxamine.
Dolasetron The risk or severity of QTc prolongation can be increased when Famphur is combined with Dolasetron.
Roxithromycin The risk or severity of QTc prolongation can be increased when Famphur is combined with Roxithromycin.
Nalidixic acid The risk or severity of QTc prolongation can be increased when Famphur is combined with Nalidixic acid.
Cinoxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Cinoxacin.
Loperamide The risk or severity of QTc prolongation can be increased when Famphur is combined with Loperamide.
Granisetron The risk or severity of QTc prolongation can be increased when Famphur is combined with Granisetron.
Ondansetron The risk or severity of QTc prolongation can be increased when Famphur is combined with Ondansetron.
Levosimendan The risk or severity of QTc prolongation can be increased when Famphur is combined with Levosimendan.
Mesoridazine The risk or severity of QTc prolongation can be increased when Famphur is combined with Mesoridazine.
Desloratadine The risk or severity of QTc prolongation can be increased when Famphur is combined with Desloratadine.
Telithromycin The risk or severity of QTc prolongation can be increased when Famphur is combined with Telithromycin.
Lomefloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Lomefloxacin.
Dimenhydrinate The risk or severity of QTc prolongation can be increased when Famphur is combined with Dimenhydrinate.
Primaquine The risk or severity of QTc prolongation can be increased when Famphur is combined with Primaquine.
Papaverine The risk or severity of QTc prolongation can be increased when Famphur is combined with Papaverine.
Chlorpheniramine The risk or severity of QTc prolongation can be increased when Famphur is combined with Chlorpheniramine.
Nifedipine The risk or severity of QTc prolongation can be increased when Famphur is combined with Nifedipine.
Levofloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Levofloxacin.
Gemifloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Gemifloxacin.
Ofloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Ofloxacin.
Propafenone The risk or severity of QTc prolongation can be increased when Famphur is combined with Propafenone.
Flecainide The risk or severity of QTc prolongation can be increased when Famphur is combined with Flecainide.
Clarithromycin The risk or severity of QTc prolongation can be increased when Famphur is combined with Clarithromycin.
Levacetylmethadol The risk or severity of QTc prolongation can be increased when Famphur is combined with Levacetylmethadol.
Saquinavir The risk or severity of QTc prolongation can be increased when Famphur is combined with Saquinavir.
Clomipramine The risk or severity of QTc prolongation can be increased when Famphur is combined with Clomipramine.
Mibefradil The risk or severity of QTc prolongation can be increased when Famphur is combined with Mibefradil.
Probucol The risk or severity of QTc prolongation can be increased when Famphur is combined with Probucol.
Aceprometazine The risk or severity of QTc prolongation can be increased when Famphur is combined with Aceprometazine.
Terlipressin The risk or severity of QTc prolongation can be increased when Famphur is combined with Terlipressin.
Prenylamine The risk or severity of QTc prolongation can be increased when Famphur is combined with Prenylamine.
Fluspirilene The risk or severity of QTc prolongation can be increased when Famphur is combined with Fluspirilene.
Lofexidine The risk or severity of QTc prolongation can be increased when Famphur is combined with Lofexidine.
Azimilide The risk or severity of QTc prolongation can be increased when Famphur is combined with Azimilide.
Pracinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Pracinostat.
Technetium Tc-99m ciprofloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Technetium Tc-99m ciprofloxacin.
Garenoxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Garenoxacin.
Tedisamil The risk or severity of QTc prolongation can be increased when Famphur is combined with Tedisamil.
Tucidinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Tucidinostat.
Telavancin The risk or severity of QTc prolongation can be increased when Famphur is combined with Telavancin.
Pazopanib The risk or severity of QTc prolongation can be increased when Famphur is combined with Pazopanib.
Nemonoxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Nemonoxacin.
Panobinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Panobinostat.
Nilvadipine The risk or severity of QTc prolongation can be increased when Famphur is combined with Nilvadipine.
Antazoline The risk or severity of QTc prolongation can be increased when Famphur is combined with Antazoline.
Crizotinib The risk or severity of QTc prolongation can be increased when Famphur is combined with Crizotinib.
Bedaquiline The risk or severity of QTc prolongation can be increased when Famphur is combined with Bedaquiline.
Fendiline The risk or severity of QTc prolongation can be increased when Famphur is combined with Fendiline.
Eperisone The risk or severity of QTc prolongation can be increased when Famphur is combined with Eperisone.
Butriptyline The risk or severity of QTc prolongation can be increased when Famphur is combined with Butriptyline.
Ceritinib The risk or severity of QTc prolongation can be increased when Famphur is combined with Ceritinib.
Lenvatinib The risk or severity of QTc prolongation can be increased when Famphur is combined with Lenvatinib.
Melperone The risk or severity of QTc prolongation can be increased when Famphur is combined with Melperone.
Benidipine The risk or severity of QTc prolongation can be increased when Famphur is combined with Benidipine.
Dexchlorpheniramine maleate The risk or severity of QTc prolongation can be increased when Famphur is combined with Dexchlorpheniramine maleate.
Amifampridine The risk or severity of QTc prolongation can be increased when Famphur is combined with Amifampridine.
Mocetinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Mocetinostat.
Entinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Entinostat.
Gilteritinib The risk or severity of QTc prolongation can be increased when Famphur is combined with Gilteritinib.
CUDC-101 The risk or severity of QTc prolongation can be increased when Famphur is combined with CUDC-101.
Simendan The risk or severity of QTc prolongation can be increased when Famphur is combined with Simendan.
Ricolinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Ricolinostat.
Mizolastine The risk or severity of QTc prolongation can be increased when Famphur is combined with Mizolastine.
Abexinostat The risk or severity of QTc prolongation can be increased when Famphur is combined with Abexinostat.
Oxatomide The risk or severity of QTc prolongation can be increased when Famphur is combined with Oxatomide.
Sitafloxacin The risk or severity of QTc prolongation can be increased when Famphur is combined with Sitafloxacin.
Sultopride The risk or severity of QTc prolongation can be increased when Famphur is combined with Sultopride.
Otilonium The risk or severity of QTc prolongation can be increased when Famphur is combined with Otilonium.
Nizofenone The risk or severity of QTc prolongation can be increased when Famphur is combined with Nizofenone.
Bunaftine The risk or severity of QTc prolongation can be increased when Famphur is combined with Bunaftine.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 4032636
    Franson JC, Kolbe EJ, Carpenter JW: Famphur toxicosis in a bald eagle. J Wildl Dis. 1985 Jul;21(3):318-20.
  • PMID: 869822
    Cummins LJ: Cow fertility after lice treatment with famphur. Aust Vet J. 1977 Apr;53(4):200.
  • PMID: 588171
    Cummins LJ: Cow fertility after lice treatment with famphur. Aust Vet J. 1977 Aug;53(8):406-7.
  • PMID: 4483149
    Johnson WP, Alford BT, Drain JJ: Safety of famphur to young Brahman heifers, bulls and steers. Vet Med Small Anim Clin. 1972 Jun;67(6):686.
  • PMID: 5465142
    Erne K, Nordkvist M: The disappearance rate in reindeer of famphur an organophosphorus parasiticide. Acta Vet Scand. 1970;11(2):209-18.
  • PMID: 7447135
    Randell WF, Bradley RE: Effects of injectable famphur on young Brahman and Angus cattle. Am J Vet Res. 1980 Sep;41(9):1423-6.
  • PMID: 1254545
    Ivey MC: Gas-liquid chromatographic determination of famphur and its oxygen analog in tissues of reindeer and cattle. J Assoc Off Anal Chem. 1976 Mar;59(2):261-3.
  • PMID: 7284948
    Watson K, Black WD: Whole blood cholinesterase activity in calves after topical treatment with famphur. Can Vet J. 1981 Jun;22(6):179-81.
Menampilkan 8 dari 10 artikel.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul